Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
These medicines are helping millions of Americans better control blood sugar levels and achieve meaningful weight loss
In an emailed statement to Newsday, pharmaceutical company Novo Nordisk, which manufactures drugs with semaglutide, said that "NAION is a very rare eye disease, and it is not an adverse drug reaction for the marketed formulations of semaglutide (Ozempic, Rybelsus and Wegovy) as per the approved labels in the U.S." The company said their own assessment of the data is that there is no proof that their drugs cause vision loss
Whats more, the studies we do have suggest that some injectable peptides could trigger abnormal immune system responses, leading to allergic reactions (including severe ones like anaphylaxis) or autoimmune issues in some people
The cost-effectiveness argument for these medications strengthens when considering avoided healthcare costs from obesity-related conditions: type 2 diabetes treatment, cardiovascular interventions, joint replacements, and MASH progression
